Pregled bibliografske jedinice broj: 740879
Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK Intergroup
Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK Intergroup // The Breast, 23 (2014), 5; 511-525 doi:10.1016/j.breast.2014.05.023 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 740879 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK Intergroup
Autori
Rordorf, Tamara ; Hassan, A. A. ; Azim, H. ; Alexandru, E. ; Er, O. ; Gokmen, E. ; Güral, Z. ; Mardiak, J. ; Minchev, V. ; Peintinger, F. ; Szendroi, M. ; Takac, I. ; Tesarova, P. ; Vorobiof, D. ; Vrbanec, Damir ; Yildiz, R. ; Yücel, S. ; Zekri, J. ; Oyan, B.
Izvornik
The Breast (0960-9776) 23
(2014), 5;
511-525
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
breast cancer ; bone health ; bisphosponated ; denosunab
Sažetak
Bone is the most common site of distant metastases in breast cancer that can cause severe and debilitating skeletal related events (SRE) including hypercalcemia of malignancy, pathologic fracture, spinal cord compression and the need for palliative radiation therapy or surgery to the bone. SRE are associated with substantial pain and morbidity leading to frequent hospitalization, impaired quality of life and poor prognosis. The past 25 years of research on the pathophysiology of bone metastases led to the development of highly effective treatment options to delay or prevent osseous metastases and SRE. Management of bone metastases has become an integral part of cancer treatment requiring expertise of multidisciplinary teams of medical and radiation oncologists, surgeons and radiologists in order to find an optimal treatment for each individual patient. A group of international breast cancer experts attended a Skeletal Care Academy Meeting in November 2012 in Istanbul and discussed current preventive measures and treatment options of SRE, which are summarized in this evidence- based consensus for qualified decision- making in clinical practice.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
MZOS-108-1080058-0046 - KARCINOM DOJKE-MOLEKULARNE,GENETSKE I KLINIČKE KARAKTERISTIKE (Vrbanec, Damir, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Damir Vrbanec
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE